US2012094916A1PendingUtilityA1

Altering memory by affecting staufen function

55
Assignee: TULLY TIMOTHY PPriority: Jun 25, 2002Filed: Nov 28, 2011Published: Apr 19, 2012
Est. expiryJun 25, 2022(expired)· nominal 20-yr term from priority
G01N 2500/00G01N 33/5088A61P 25/28G01N 33/6896G01N 33/5035G01N 33/5023G01N 33/5008G01N 33/5058A61P 25/00G01N 33/502
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides methods for screening a pharmaceutical agent for its ability to modulate long term memory formation, performance of a hippocampal-dependent cognitive task or STAUFEN function. The present invention also provides methods for modulating long term memory formation or performance of a hippocampal-dependent cognitive task by modulating staufen-dependent protein expression. The present invention further provides methods for treating a defect in long term memory formation associated with a defect in STAUFEN and methods for treating a defect in performance of a hippocampal-dependent cognitive task associated with a defect in STAUFEN.

Claims

exact text as granted — not AI-modified
1 . (canceled) 
     
     
         2 . (canceled) 
     
     
         3 . (canceled) 
     
     
         4 . (canceled) 
     
     
         5 . (canceled) 
     
     
         6 . (canceled) 
     
     
         7 . (canceled) 
     
     
         8 . (canceled) 
     
     
         9 . (canceled) 
     
     
         10 . (canceled) 
     
     
         11 . (canceled) 
     
     
         12 . (canceled) 
     
     
         13 . (canceled) 
     
     
         14 . (canceled) 
     
     
         15 . (canceled) 
     
     
         16 . (canceled) 
     
     
         17 . (canceled) 
     
     
         18 . (canceled) 
     
     
         19 . (canceled) 
     
     
         20 . A method of modulating long term memory formation in a mammal comprising modulating STAUFEN function in said animal. 
     
     
         21 . The method of  claim 20 , wherein long term memory formation is enhanced. 
     
     
         22 . The method of  claim 20 , wherein modulating STAUFEN function comprises administering to said mammal a pharmaceutical agent which modulates STAUFEN function in said mammal, in an amount effective to modulate STAUFEN function in said mammal. 
     
     
         23 . The method of  claim 20 , wherein said mammal is a rodent or a human. 
     
     
         24 . The method of  claim 20  comprising modulating STAUFEN protein expression in said mammal. 
     
     
         25 . The method of  claim 24 , wherein long term memory formation is enhanced. 
     
     
         26 . (canceled) 
     
     
         27 . (canceled) 
     
     
         28 . (canceled) 
     
     
         29 . (canceled) 
     
     
         30 . (canceled) 
     
     
         31 . (canceled) 
     
     
         32 . (canceled) 
     
     
         33 . (canceled) 
     
     
         34 . (canceled) 
     
     
         35 . (canceled) 
     
     
         36 . (canceled) 
     
     
         37 . (canceled) 
     
     
         38 . (canceled) 
     
     
         39 . (canceled) 
     
     
         40 . (canceled) 
     
     
         41 . (canceled) 
     
     
         42 . (canceled) 
     
     
         43 . (canceled) 
     
     
         44 . (canceled) 
     
     
         45 . (canceled) 
     
     
         46 . (canceled) 
     
     
         47 . (canceled) 
     
     
         48 . (canceled) 
     
     
         49 . (canceled) 
     
     
         50 . (canceled) 
     
     
         51 . (canceled) 
     
     
         52 . (canceled) 
     
     
         53 . (canceled) 
     
     
         54 . (canceled) 
     
     
         55 . (canceled) 
     
     
         56 . (canceled) 
     
     
         57 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.